XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
BD 1 Notes (related party)
Nanyang Convertible Notes
Fleur Note
Global Ichiban Convertible Note
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series 1A Preferred Stock
Preferred Stock
Series 1A Preferred Stock
TubeSolar
Preferred Stock
Crowdex Convertible Notes
Series 1A Preferred Stock
Common Stock
Common Stock
TubeSolar
Common Stock
BD 1 Notes (related party)
Common Stock
Crowdex Convertible Notes
Common Stock
Nanyang Convertible Notes
Common Stock
Fleur Note
Common Stock
Global Ichiban Convertible Note
Additional Paid-In Capital
Additional Paid-In Capital
TubeSolar
Additional Paid-In Capital
BD 1 Notes (related party)
Additional Paid-In Capital
Crowdex Convertible Notes
Additional Paid-In Capital
Nanyang Convertible Notes
Additional Paid-In Capital
Fleur Note
Additional Paid-In Capital
Global Ichiban Convertible Note
Accumulated Deficit
Other Comprehensive Loss
Beginning balance at Dec. 31, 2020 $ (20,192,203)         $ 5       $ 366             $ 401,590,211             $ (421,782,785)  
Beginning balance (in shares) at Dec. 31, 2020           48,100 1,300     3,659,828                              
Proceeds from issuance of Series 1A Preferred Stock 2,500,000                               2,500,000                
Proceeds from issuance of Series 1A Preferred Stock (in shares)             2,500                                    
Proceeds from issuance of Common Stock 3,000,000                 $ 2             2,999,998                
Proceeds from issuance of common stock (in shares)                   1,500                              
Conversion of shares         $ 5,800,000                     $ 3             $ 5,799,997    
Conversion of shares (in shares)                               33,600                  
Relieved on Conversion of Derivative Liability 1,686,079                               1,686,079                
Net Income 1,846,384                                             1,846,384  
Ending balance at Mar. 31, 2021 (5,359,740)         $ 5       $ 371             414,576,285             (419,936,401)  
Ending balance (in shares) at Mar. 31, 2021           48,100 3,800     3,694,928                              
Beginning balance at Dec. 31, 2021 (2,833,606)         $ 5       $ 479             424,948,698             (427,782,788)  
Beginning balance (in shares) at Dec. 31, 2021           48,100 3,700     4,786,804                              
Conversion of shares   $ 7,900,000 $ 600,000 $ 700,000             $ 480 $ 1,580 $ 260 $ 120 $ 140     $ (480) $ 7,898,420 $ (260) $ 599,880 $ 699,860      
Conversion of shares (in shares)               (2,400) (1,300)   4,800,000 15,800,000 2,600,000 1,200,000 1,400,000                    
Net Income (4,297,249)                                             (4,297,249)  
Foreign currency translation gain/(loss) (7,097)                                               $ (7,097)
Ending balance at Mar. 31, 2022 $ 2,062,048         $ 5       $ 3,059             $ 434,146,118             $ (432,080,037) $ (7,097)
Ending balance (in shares) at Mar. 31, 2022           48,100       30,586,804